序号 |
标题 |
次数 |
作者 |
发布时间 |
75286 |
HS-(CH2)3-PEG2-OCH2-COOH 巯基-三烷烃-二聚乙二醇-OCH2-羧基 |
130 |
h |
2024-12-20 |
75287 |
HS-C11-PEG6-NH2 巯基-C11-六聚乙二醇-氨基 |
75 |
h |
2024-12-20 |
75288 |
HS-(CH2)8-PEG12-NH3+ Cl- 巯基-八烷烃-十二聚乙二醇-NH3+ Cl- |
143 |
h |
2024-12-20 |
75289 |
HS-(CH2)5-PEG8-NH3+ Cl- 巯基-5烷烃-八聚乙二醇-NH3+ Cl- |
134 |
h |
2024-12-20 |
75290 |
HS-(CH2)11-PEG4-NH3+ Cl- 巯基-十一烷烃-四聚乙二醇-NH3+ Cl- |
117 |
h |
2024-12-20 |
75291 |
HS-C6-PEG3 巯基-6烷烃-三聚乙二醇 |
139 |
h |
2024-12-20 |
75292 |
HS-C11-PEG 巯基-11烷烃-聚乙二醇 |
101 |
h |
2024-12-20 |
75293 |
HS-(CH2)3-EG12-OH 巯基-三烷烃-十二聚乙二醇-羟基 |
118 |
h |
2024-12-20 |
75294 |
HS-(CH2)11-EG2-OH 巯基-11烷烃-二聚乙二醇-羟基 |
94 |
h |
2024-12-20 |
75295 |
HS-(CH2)6-EG3-OH 巯基-六烷烃-三聚乙二醇-羟基 |
106 |
h |
2024-12-20 |
75296 |
(MeO)3Si-(CH2)6-OC(O)- IzoButyrate-Br (MeO)3硅-六烷烃-OC(O)- IzoButyrate-Br |
95 |
h |
2024-12-20 |
75297 |
HS-C6-DMAPS |
91 |
h |
2024-12-20 |
75298 |
Au-S-Polymer-Doxorubicin 金-硫-聚合物-阿霉素 |
94 |
h |
2024-12-20 |
75299 |
(S-(EG)3-CH2-CONH-Fluorescein)2 硫-三聚乙二醇-烷烃-CONH-荧光素 |
100 |
h |
2024-12-19 |
75300 |
Ag_55_C15COOH 银团簇55-C15-羧基 |
80 |
h |
2024-12-19 |
75301 |
Ag-S-(CH2)11-NH3+Cl- 银-硫-十一烷烃-NH3+Cl- |
111 |
h |
2024-12-19 |
75302 |
Au-S-Zwitterion 金-硫-两性离子 |
109 |
h |
2024-12-19 |
75303 |
Au_12_C11NMe3 金12碳11纳米团簇 |
96 |
h |
2024-12-19 |
75304 |
Au_55_C10COOH 金团簇55-C10-羧酸 |
79 |
h |
2024-12-19 |
75305 |
Au-S-(CH2)10-C(O)-CH3 金-硫-直链烷烃10-碳(氧)-甲烷3 |
115 |
h |
2024-12-19 |
75306 |
MC-Val-Cit-PAB-tubulysin5a ,CAS号:2055896-86-9 |
71 |
WYQ |
2024-12-19 |
75307 |
Au_55_C11NH3Cl 金55-C11-NH3Cl |
102 |
h |
2024-12-19 |
75308 |
(S-(CH2)11-(beta-Lactose(SO4Na)7)2 硫-十一烷烃-β-乳糖 |
121 |
h |
2024-12-19 |
75309 |
HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 |
176 |
h |
2024-12-19 |
75310 |
HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 |
123 |
h |
2024-12-19 |
75311 |
cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS |
123 |
kx |
2024-12-19 |
75312 |
4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) |
120 |
kx |
2024-12-19 |
75313 |
cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 |
118 |
kx |
2024-12-19 |
75314 |
perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) |
127 |
kx |
2024-12-19 |
75315 |
cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 |
98 |
kx |
2024-12-19 |
75316 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 |
82 |
kx |
2024-12-19 |
75317 |
cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) |
140 |
kx |
2024-12-19 |
75318 |
cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 |
140 |
kx |
2024-12-19 |
75319 |
MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 |
89 |
WYQ |
2024-12-19 |
75320 |
cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 |
102 |
kx |
2024-12-19 |
75321 |
mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) |
90 |
WYQ |
2024-12-19 |
75322 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
97 |
wyh |
2024-12-19 |
75323 |
MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) |
97 |
WYQ |
2024-12-19 |
75324 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
75 |
wyh |
2024-12-19 |
75325 |
MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) |
92 |
WYQ |
2024-12-19 |
75326 |
N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB |
121 |
kx |
2024-12-19 |
75327 |
MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) |
82 |
WYQ |
2024-12-19 |
75328 |
MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 |
107 |
WYQ |
2024-12-19 |
75329 |
叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB |
87 |
kx |
2024-12-19 |
75330 |
MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 |
108 |
WYQ |
2024-12-19 |